|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Dipyridamole#Structure]] |
| {{Dipyridamole}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Description==
| |
| PERSANTINE® (dipyridamole USP) is a platelet inhibitor chemically described as 2,2',2",2"'-[(4,8- Dipiperidinopyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]-tetraethanol. It has the following structural formula:
| |
| {|
| |
| |-
| |
| |[[File:Dipyriamole01.gif|thumb|1200px]]
| |
| |-
| |
| |}
| |
| | |
| {|
| |
| |-
| |
| |[[File:Dipyriamole03.jpg|thumb|800px]]
| |
| |-
| |
| |}
| |
| Dipyridamole is an odorless yellow crystalline powder, having a bitter taste. It is soluble in dilute acids, methanol and chloroform, and practically insoluble in water. | |
| | |
| PERSANTINE tablets for oral administration contain:
| |
| | |
| Active IngredientTABLETS 25 mg, 50 mg, and 75 mg: dipyridamole USP 25 mg , 50 mg and 75 mg, respectively.
| |
| | |
| Inactive IngredientsTABLETS 25 mg, 50 mg, and 75 mg: acacia, carnauba wax, corn starch, edible white ink, lactose monohydrate, magnesium stearate, D&C yellow #10 aluminum lake, D&C red #30, helendon aluminum pink lake, sodium benzoate, methylparaben, propylparaben, polyethylene glycol, povidone, sucrose, talc, titanium dioxide, and white wax.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = PERSANTINE (DIPYRIDAMOLE) TABLET, COATED [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ca68879c-0214-4d7c-93b0-bdaf8ef23f8e | publisher = | date = | accessdate = 7 February 2014 }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Antiplatelet drugs]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |